Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
3
×
san francisco blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas top stories
wisconsin blog main
wisconsin top stories
arvinas
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bill &
bluebird bio
boston
cancer autoimmune diseases. peloton therapeutics
cedilla therapeutics
clinical trials
dana-farber cancer institute
democrats
donald
What
long
3
×
drug
adapt
ago
anathema
awaited
biotechs
cells
cellular
changes
considering
data
democrat
details
diseases
dyne
early
elements
expected
experimental
eyes
genetic
goes
having
house
humans
importance
ipo
ipos
known
leaked
led
levels
look
lower
medicine
medicines
monday
muscle
night
Language
unset
3
×
Current search:
biotech
×
long
×
" san diego blog main "
×
" boston top stories "
×
unset
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly